These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17314670)
1. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Funayama M; Li Y; Tomiyama H; Yoshino H; Imamichi Y; Yamamoto M; Murata M; Toda T; Mizuno Y; Hattori N Neuroreport; 2007 Feb; 18(3):273-5. PubMed ID: 17314670 [TBL] [Abstract][Full Text] [Related]
2. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population. Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095 [TBL] [Abstract][Full Text] [Related]
3. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369 [TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease. Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942 [TBL] [Abstract][Full Text] [Related]
5. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822 [TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease. Deng H; Le W; Huang M; Xie W; Pan T; Jankovic J Neurosci Lett; 2007 May; 419(2):104-7. PubMed ID: 17482357 [TBL] [Abstract][Full Text] [Related]
7. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. Fung HC; Chen CM; Hardy J; Singleton AB; Wu YR BMC Neurol; 2006 Dec; 6():47. PubMed ID: 17187665 [TBL] [Abstract][Full Text] [Related]
8. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Tan EK; Shen H; Tan LC; Farrer M; Yew K; Chua E; Jamora RD; Puvan K; Puong KY; Zhao Y; Pavanni R; Wong MC; Yih Y; Skipper L; Liu JJ Neurosci Lett; 2005 Aug; 384(3):327-9. PubMed ID: 15955629 [TBL] [Abstract][Full Text] [Related]
9. Analysis of LRRK2 functional domains in nondominant Parkinson disease. Skipper L; Shen H; Chua E; Bonnard C; Kolatkar P; Tan LC; Jamora RD; Puvan K; Puong KY; Zhao Y; Pavanni R; Wong MC; Yuen Y; Farrer M; Liu JJ; Tan EK Neurology; 2005 Oct; 65(8):1319-21. PubMed ID: 16247070 [TBL] [Abstract][Full Text] [Related]
10. LRRK2: both a cause and a risk factor for Parkinson disease? Foroud T Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895 [No Abstract] [Full Text] [Related]
11. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265 [TBL] [Abstract][Full Text] [Related]
12. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909 [TBL] [Abstract][Full Text] [Related]
13. The role of common genetic risk variants in Parkinson disease. Tan EK Clin Genet; 2007 Nov; 72(5):387-93. PubMed ID: 17868389 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the LRRK2 Gly2385Arg variant in Alzheimer's disease in Taiwan. Chang TY; Kuo HC; Lu CS; Wu-Chou YH; Huang CC Parkinsonism Relat Disord; 2010 Jan; 16(1):28-30. PubMed ID: 19640773 [TBL] [Abstract][Full Text] [Related]
15. A study of LRRK2 mutations and Parkinson's disease in Brazil. Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824 [TBL] [Abstract][Full Text] [Related]
16. Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China. Cai J; Lin Y; Chen W; Lin Q; Cai B; Wang N; Zheng W Neurol Sci; 2013 Nov; 34(11):2001-6. PubMed ID: 23624603 [TBL] [Abstract][Full Text] [Related]
17. No TARDBP mutations in a French Canadian population of patients with Parkinson disease. Kabashi E; Daoud H; Rivière JB; Valdmanis PN; Bourgouin P; Provencher P; Pourcher E; Dion P; Dupré N; Rouleau GA Arch Neurol; 2009 Feb; 66(2):281-2. PubMed ID: 19204172 [No Abstract] [Full Text] [Related]
18. Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families. Ohta E; Hasegawa K; Gasser T; Obata F Neurosci Lett; 2007 Apr; 417(1):21-3. PubMed ID: 17395370 [TBL] [Abstract][Full Text] [Related]
19. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901 [TBL] [Abstract][Full Text] [Related]
20. Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. Zabetian CP; Morino H; Ujike H; Yamamoto M; Oda M; Maruyama H; Izumi Y; Kaji R; Griffith A; Leis BC; Roberts JW; Yearout D; Samii A; Kawakami H Neurology; 2006 Aug; 67(4):697-9. PubMed ID: 16728648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]